These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30305776)

  • 1. A Pilot Study on the Comparison between Planning Target Volume-based Intensity-Modulated Proton Therapy Plans and Robustly Optimized Intensity-Modulated Proton Therapy Plans.
    Perumal B; Sundaresan HE; Vaitheeswaran R
    J Med Phys; 2018; 43(3):179-184. PubMed ID: 30305776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
    Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
    Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
    Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust optimization of intensity modulated proton therapy.
    Liu W; Zhang X; Li Y; Mohan R
    Med Phys; 2012 Feb; 39(2):1079-91. PubMed ID: 22320818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
    An Y; Liang J; Schild SE; Bues M; Liu W
    Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.
    van Dijk LV; Steenbakkers RJ; ten Haken B; van der Laan HP; van 't Veld AA; Langendijk JA; Korevaar EW
    PLoS One; 2016; 11(3):e0152477. PubMed ID: 27030987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
    Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J
    Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SU-E-T-624: Comparison of PTV+PRV-Based Optimization and Robust Optimization in Intensity-Modulated Proton Therapy.
    Liu W; Zhu X; Li X; Li Y; Zhang X; Frank S; Mohan R
    Med Phys; 2012 Jun; 39(6Part20):3849-3850. PubMed ID: 28517515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
    Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
    Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.
    Teoh S; George B; Fiorini F; Vallis KA; Van den Heuvel F
    Br J Radiol; 2020 Mar; 93(1107):20190584. PubMed ID: 31977241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
    Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
    Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of IMPT versus VMAT plans using different uncertainty scenarios for prostate cancer.
    Butkus MP; Brovold N; Diwanji T; Xu Y; De Ornelas M; Dal Pra A; Abramowitz M; Pollack A; Dogan N
    Radiat Oncol; 2022 Sep; 17(1):162. PubMed ID: 36175971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust mixed electron-photon radiation therapy optimization.
    Renaud MA; Serban M; Seuntjens J
    Med Phys; 2019 Mar; 46(3):1384-1396. PubMed ID: 30628079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
    Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
    Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of daily dose accumulation for robustly optimized intensity modulated proton therapy treatment of prostate cancer.
    Xu Y; Diwanji T; Brovold N; Butkus M; Padgett KR; Schmidt RM; King A; Dal Pra A; Abramowitz M; Pollack A; Dogan N
    Phys Med; 2021 Jan; 81():77-85. PubMed ID: 33445124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.
    Li H; Zhang X; Park P; Liu W; Chang J; Liao Z; Frank S; Li Y; Poenisch F; Mohan R; Gillin M; Zhu R
    Radiother Oncol; 2015 Mar; 114(3):367-72. PubMed ID: 25708992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
    Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.